Results 211 to 220 of about 5,135,152 (380)

Bioinformatics roadmap for therapy selection in cancer genomics. [PDF]

Mol Oncol, 2022
Jiménez-Santos MJ, García-Martín S, Fustero-Torre C, Di Domenico T, Gómez-López G, Al-Shahrour F.   +5 more
europepmc   +1 more source

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

Clinical reporting for personalized cancer genomics requires extensive access to subscription-only literature. [PDF]

J Med Libr Assoc, 2023
D'Souza S, Downs G, Hendrikx S, Fazelzad R, Boldt G, Burns K, Chapman D, Dawes D, Giannarakos A, Oja LA, Schorr R, Babb M, Hodgson A, McEwan J, Jacobs P, Stockley T, Tripp T, King I.   +17 more
europepmc   +1 more source

Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families [PDF]

, 2003
Marco Montagna
openalex   +1 more source

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

Breast Cancer Genomics: Primary and Most Common Metastases. [PDF]

Cancers (Basel), 2022
Bennett C, Carroll C, Wright C, Awad B, Park JM, Farmer M, Brown EB, Heatherly A, Woodard S.   +8 more
europepmc   +1 more source

Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer [PDF]

, 2003
Gunnar B. Kristensen, Wanja Kildal, Vera M. Abeler, J. Kærn, Ignace Vergote, Claes G. Tropé, Håvard E. Danielsen   +6 more
openalex   +1 more source

Cancer genetics or cancer genomics in the era of genomic medicine? [PDF]

Annals of Oncology, 2003
openaire   +2 more sources

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Increased cell proliferation is associated with genomic instability: elevated micronuclei frequencies in estradiol-treated human ovarian cancer cells [PDF]

, 2003
Helga Stopper
openalex   +1 more source